Drugs / LV [arm: experimental] — 400mg/m\^2, d1, 14 days per cycle, 8 cycles.
LV [arm: experimental] — 400mg/m\^2, d1, 14 days per cycle, 8 cycles.
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT06341296 Background | Jun 2024 → Apr 2026 overdue | colorectal cancer | West China Hospital | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LV [arm: experimental] — 400mg/m\^2, d1, 14 days per cycle, 8 cycles. | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06341296 ↗ |